Bacterial induction of early response genes and activation of proapoptotic factors in pleural mesothelial cells.

Kamal A Mohammed, Najmunnisa Nasreen, Veena B Antony
Author Information
  1. Kamal A Mohammed: Department of Medicine, College of Medicine, University of Florida, JHMHC, P.O. Box 100225, Gainesville, Florida, 32610-0225, USA. mkamal@medicine.ufl.edu

Abstract

In bacterial empyema the pleural mesothelium is constantly exposed to microorganisms. Staphylococcus aureus (S. aureus) is one of the most frequent pathogens associated with empyema. In an earlier study we demonstrated that S. aureus induced barrier dysfunction in pleural mesothelial cell monolayers. In the present study we report that S. aureus activates the early response genes c-fos and c-jun and activator protein-1 (AP-1), and induces proapoptosis genes Bad and Bak in primary mouse pleural mesothelial cells (PMCs). Our data indicate that in PMCs S. aureus induces apoptosis in a time- and multiplicity of infection (MOI)-dependent manner. Staphylococcus aureus induced Bcl (2), Bcl-X (L), c-fos, c-jun, and AP-1 expression in PMCs during the initial phase of infection. In S. aureus-infected PMCs, Bad and Bak gene expression was increased and correlated with DNA fragmentation and cytochrome-c release. Bcl (2) and Bcl-X (L) gene expression was significantly lower in S. aureus-infected PMCs than in uninfected PMCs 12 h postinfection. We conclude that at the initial stage of infection S. aureus modulates expression of early response genes c-fos and c-jun, and in the late phase of infection S. aureus induces expression of proapoptotic genes Bak and Bad in PMCs. Silencing AP-1 significantly inhibited S. aureus-induced Bak and Bad expression in PMCs. The upregulation of early response genes during the early phase of infection may contribute to the activation of proapoptotic genes Bak and Bad and release of cytochrome-c, caspase-3 thereby resulting in apoptosis in PMCs.

References

  1. Biochem Biophys Res Commun. 1992 Nov 16;188(3):1261-6 [PMID: 1445359]
  2. Biochem Pharmacol. 2003 Jul 1;66(1):93-103 [PMID: 12818369]
  3. Crit Rev Oncol Hematol. 1994 Oct;17(2):93-131 [PMID: 7818789]
  4. J Cell Sci. 2004 Dec 1;117(Pt 25):5965-73 [PMID: 15564374]
  5. J Biol Chem. 1992 Sep 15;267(26):18278-83 [PMID: 1526968]
  6. J Clin Invest. 1990 Nov;86(5):1517-23 [PMID: 2122980]
  7. Nature. 1996 Mar 7;380(6569):75-9 [PMID: 8598911]
  8. Kidney Int. 2006 Sep;70(6):1089-98 [PMID: 16871245]
  9. Cell Growth Differ. 1996 Aug;7(8):1087-94 [PMID: 8853905]
  10. Mol Biol Cell. 1994 Apr;5(4):455-64 [PMID: 8054686]
  11. Am J Physiol Lung Cell Mol Physiol. 2001 Jul;281(1):L119-25 [PMID: 11404254]
  12. Semin Respir Infect. 1999 Mar;14(1):3-8 [PMID: 10197392]
  13. J Immunol Methods. 1991 Jun 3;139(2):271-9 [PMID: 1710634]
  14. J Infect Dis. 2000 May;181(5):1693-9 [PMID: 10823770]
  15. Mol Pharmacol. 1990 Oct;38(4):435-9 [PMID: 2122229]
  16. Nature. 1995 Apr 20;374(6524):733-6 [PMID: 7715730]
  17. Infect Immun. 2000 May;68(5):2998-3001 [PMID: 10769002]
  18. Pediatr Infect Dis. 1984 Nov-Dec;3(6):578-91 [PMID: 6514596]
  19. Infect Immun. 1986 Dec;54(3):833-6 [PMID: 3781627]
  20. Biochem J. 1997 Aug 15;326 ( Pt 1):1-16 [PMID: 9337844]
  21. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):595-600 [PMID: 10673205]
  22. J Cell Biol. 1989 Oct;109(4 Pt 1):1597-608 [PMID: 2507553]
  23. Behring Inst Mitt. 1996 Oct;(97):72-100 [PMID: 8950468]
  24. Infect Immun. 1985 Oct;50(1):218-24 [PMID: 4044035]
  25. BMC Microbiol. 2006 Mar 08;6:26 [PMID: 16524480]
  26. Cell. 1983 Aug;34(1):245-53 [PMID: 6192933]
  27. Anat Rec. 1973 Nov;177(3):409-26 [PMID: 4127780]
  28. Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129-57 [PMID: 1751545]
  29. J Biol Chem. 2006 Apr 21;281(16):11250-9 [PMID: 16436379]
  30. Apoptosis. 2001 Dec;6(6):431-9 [PMID: 11595832]
  31. Infect Immun. 1998 Dec;66(12):5994-8 [PMID: 9826383]
  32. Nature. 1993 May 13;363(6425):166-9 [PMID: 8483500]
  33. Nat Rev Cancer. 2003 Nov;3(11):859-68 [PMID: 14668816]
  34. Trends Biochem Sci. 2001 Jan;26(1):61-6 [PMID: 11165519]
  35. Mol Cell Biol. 1996 Jan;16(1):211-8 [PMID: 8524298]
  36. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3299-303 [PMID: 8386370]
  37. J Exp Med. 1996 Apr 1;183(4):1293-5 [PMID: 8666886]
  38. Science. 1995 Mar 10;267(5203):1456-62 [PMID: 7878464]
  39. Curr Opin Cell Biol. 1997 Apr;9(2):240-6 [PMID: 9069263]
  40. Chest. 2000 Apr;117(4):1017-22 [PMID: 10767233]
  41. Clin Infect Dis. 1996 Jun;22(6):1057-63 [PMID: 8783710]
  42. J Lab Clin Med. 1998 Sep;132(3):202-9 [PMID: 9735926]
  43. Infect Immun. 2001 Mar;69(3):1287-97 [PMID: 11179290]
  44. Science. 2004 Jul 30;305(5684):626-9 [PMID: 15286356]
  45. Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):4997-5002 [PMID: 9560217]
  46. Indian J Pediatr. 2005 Mar;72(3):197-9 [PMID: 15812111]
  47. Infect Immun. 2001 Sep;69(9):5235-42 [PMID: 11500391]
  48. J Biol Chem. 1998 Apr 17;273(16):9357-60 [PMID: 9545256]
  49. Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1653-9 [PMID: 10228140]
  50. Infect Immun. 1998 Jan;66(1):336-42 [PMID: 9423876]
  51. Chest. 1991 May;99(5):1162-5 [PMID: 2019172]

Grants

  1. R01 AI41877-04/NIAID NIH HHS

MeSH Term

Animals
Apoptosis
Blotting, Western
Disease Models, Animal
Empyema, Pleural
Female
Gene Expression Regulation, Neoplastic
Genes, fos
Genes, jun
In Situ Nick-End Labeling
Mice
Mice, Inbred C57BL
Pleura
Polymerase Chain Reaction
Protein-Tyrosine Kinases
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-bcl-2
RNA, Neoplasm
Staphylococcal Infections
Staphylococcus aureus
Transcription Factor AP-1
bcl-X Protein

Chemicals

Bcl2l1 protein, mouse
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-bcl-2
RNA, Neoplasm
Transcription Factor AP-1
bcl-X Protein
Bcl2 protein, mouse
Protein-Tyrosine Kinases

Word Cloud

Created with Highcharts 10.0.0SPMCsaureusgenesexpressionearlyBadBakinfectionpleuralresponsemesothelialc-fosc-junAP-1inducesphaseproapoptoticempyemaStaphylococcusstudyinducedcellsapoptosisBcl2Bcl-XLinitialaureus-infectedgenecytochrome-creleasesignificantlyactivationbacterialmesotheliumconstantlyexposedmicroorganismsonefrequentpathogensassociatedearlierdemonstratedbarrierdysfunctioncellmonolayerspresentreportactivatesactivatorprotein-1proapoptosisprimarymousedataindicatetime-multiplicityMOI-dependentmannerincreasedcorrelatedDNAfragmentationloweruninfected12hpostinfectionconcludestagemodulateslateSilencinginhibitedaureus-inducedupregulationmaycontributecaspase-3therebyresultingBacterialinductionfactors

Similar Articles

Cited By